Walgreens Pays $35 Million, Settles Pharmacist-Whistleblower Qui Tam Drug Switching Allegations

CHICAGO, June 4 /PRNewswire/ -- Walgreens today became the third national pharmacy to settle drug switching allegations exposed by a whistleblowing veteran pharmacist whose actions have returned more than $120 million to federal and state governments. The cases against three of America's largest drug store chains were pursued by Chicago-based whistleblower attorneys Michael I. Behn and Linda Wyetzner under qui tam provisions of state and federal False Claims Acts.

Walgreens paid $35 million to 42 states and the Commonwealth of Puerto Rico to settle allegations it overcharged Medicaid by switching dosage forms in filling generic Prozac(R), Zantac(R) and Eldepryl(R) prescriptions, according to Behn.

Today's settlement resulted from a suit filed by Behn and Wyetzner in the United States District Court for the Northern District of Illinois. This is the third case their firm, Behn & Wyetzner, Chartered, has handled for pharmacist whistleblower Bernard Lisitza. Prior generic drug switching cases by Lisitza resulted in a $37 million settlement earlier this year with CVS Caremark Corp., owner of CVS pharmacies, and a $50 million settlement in late 2006 with Omnicare, Inc., the nation's largest pharmacy for nursing homes.

"Bernie wanted the government to know that the drug switching programs he observed were schemes to increase pharmacy profits at taxpayers' expense," Behn said. "As a professional who has filled prescriptions for decades, Bernie saw no medical benefit for the drug switching."

"The Walgreens settlement today, like CVS and Omnicare before it, shows how an alert, dedicated pharmacist whistleblower can help the government clean up an entire industry when profits are put ahead of the public trust," Behn said.

Behn praised the "unique and unparalleled coordination of state and federal prosecutors" in the Walgreens, CVS and Omnicare cases.

Today's Walgreens case is yet another successful whistleblower action brought by Behn & Wyetzner, Chartered. In addition to the Omnicare and CVS cases, Behn represented the plaintiffs in the largest whistleblower settlement in Chicago, which resulted in Northrop Grumman paying $134 million to resolve claims involving the B-2 "Stealth" bomber.

Today's settlement was achieved through the efforts of Assistant U.S. Attorney Linda A. Wawzenski, Deputy Chief of the Civil Division of the U.S. Attorney's Office for the Northern District of Illinois; Patrick Keenan, Chief of the Medicaid Fraud Bureau and Assistant Attorney General of Illinois; John Guthrie, Director of the Ohio Attorney General's Health Care Fraud Unit; Bernabe Icaza, then Assistant Attorney General of Florida; Robert Robinson, Assistant Attorney General of Texas; and several other state prosecutors working with the National Association of Medicaid Fraud Control Units ("NAMFCU"). Special Agents of the FBI, the FDA, and the Office of the Inspector General, Department of Health and Human Services, also assisted in the investigation and prosecution of the Walgreens case.

In executing the Settlement Agreement, Walgreens denied liability, wrongdoing or improper conduct.

Case: UNITED STATES OF AMERICA ex rel.BERNARD LISITZA. States ex rel. BERNARD LISITZA, and BERNARD LISITZA, individually v. WALGREENS Co., Northern District of Illinois, 03C00744.

Visit http://www.pharmacyfraudsettlement.com, a reference Web site for pharmacy fraud and pharmacist whistleblowers just updated with material and filed documents relating to the Walgreens, CVS and Omnicare qui tam whistleblower settlements. Included are filed documents, fraud allegations, applicable federal laws, and information about the experienced qui tam whistleblower attorneys from Behn & Wyetzner, Chartered who handled the Walgreens and other whistleblower cases.

About Pharmacists: As front line professionals responsible for dispensing medications to Medicaid beneficiaries, pharmacists are particularly well suited to discover and report Medicaid fraud, which is clear from the Walgreens, CVS and Omnicare cases as reported on the PharmacyFraudSettlement.com Web site.

SOURCE PRforLAW, LLC

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.